Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Concentra Group Holdings Parent, Inc. ( (CON) ) is now available.
Concentra reported strong first-quarter 2026 results on May 7, 2026, with revenue rising 13.7% year over year to $569.6 million and net income climbing 28.7% to $52.3 million, supported by higher patient visit volumes, increased revenue per visit, and a 17.6% jump in adjusted EBITDA to $120.7 million. The company also improved free cash flow to $9.9 million, maintained a net leverage ratio of 3.4x in line with its credit covenants, expanded its footprint with new and acquired centers and a sharp increase in onsite clinics, declared a $0.0625 per-share cash dividend payable in June 2026, and raised its full-year 2026 guidance for revenue, adjusted EBITDA, free cash flow, and lower leverage, underscoring confidence in its operating model and ongoing separation from Select Medical.
On May 5, 2026, Concentra’s board approved the $0.0625 per-share cash dividend for shareholders of record on May 19, 2026, reflecting the company’s willingness to return capital following robust earnings growth and positive cash generation. Management signaled that the strong first quarter and heightened guidance, including a targeted 2026 revenue range of $2.275 billion to $2.375 billion and free cash flow of $215 million to $235 million, position Concentra to invest in new locations, optimize its platform as it completes independence from Select Medical, and strengthen its role as a leading health partner for the U.S. workforce while managing leverage below 3.0x.
The most recent analyst rating on (CON) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.
Spark’s Take on CON Stock
According to Spark, TipRanks’ AI Analyst, CON is a Neutral.
The score is driven primarily by solid operating and cash-flow performance, tempered by balance-sheet leverage volatility and questions around sustainability of unusually strong 2025 profitability. Technical signals are neutral, while valuation is reasonable and corporate updates are broadly supportive.
To see Spark’s full report on CON stock, click here.
More about Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc., listed on the NYSE as CON, is the largest provider of occupational health services in the United States by number of locations. The company delivers occupational and consumer health and other direct-to-employer care through 632 occupational health centers, 411 onsite health clinics, and its Concentra Telemed platform across 47 states and Washington, D.C., serving about 54,000 patients each business day with a workforce of roughly 13,000 colleagues and affiliated clinicians.
Average Trading Volume: 715,284
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.93B
See more data about CON stock on TipRanks’ Stock Analysis page.